Skip To Main Content
Tatenda Zvidzai on Muck Rack

Tatenda Zvidzai

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tatenda

Contact Tatenda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Kinase inhibitors impact moderately differentiated wild type and mutant KRAS human pancreatic cancer cells and reveal potential therapeutic targets

|
By Ketki Patil, Jeonghwa Ma, Griffin A. Dufek, S. Pai, Anna Boezi, Tatenda Zvidzai, Sweeta Akbari
| Nature Verified
Abstract Pancreatic ductal adenocarcinoma is an aggressive form of cancer and is the seventh leading cause of cancer deaths worldwide. Thus, there is an imminent need to discover therapeutic options for the moderately differentiated pancreatic cancers to prevent their progression to poorly differentiated types.
Open in Who Shared Issue with article?
See all 1 articles